STOCKHOLM, SWEDEN / ACCESSWIRE / April 9, 2024 / In a significant leap for financial technology, GENERALIFX, a rapidly expanding name in AI-powered automated trading software and investment management consultancy, announces the launch of its latest inn…
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / April 9, 2024 / USPA Global has announced that U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has delivered a record $2.4 billion in global retail sales in 2023. The global sport…
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidateKey takeaways:Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 cli…
KONONGO, GHANA / ACCESSWIRE / February 29, 2024 / Konongo St. Gabriel’s Co-Operate Credit Union takes a bold step forward in safeguarding its digital infrastructure by partnering with OMNICOMMANDER® to bring industry-specific cybersecurity education to…
Revolutionizing the Diamond Industry NEW YORK, NY / ACCESSWIRE / February 14, 2024 / The future of third-party diamond traceability and title of ownership from true origin is here. Authentia is proud to announce its official launch in South Africa following resounding success during its Beta testing phase. Since its
Revolutionizing the Diamond IndustryNEW YORK, NY / ACCESSWIRE / February 14, 2024 / The future of third-party diamond traceability and title of ownership from true origin is here. Authentia is proud to announce its official launch in South Africa follo…
HOMA BAY, KENYA / ACCESSWIRE / January 23, 2024 / Global Partners for Development (GPFD) and 374Water, a global cleantech and social impact company, have announced plans for the Homa Bay Blueprint, a bold and comprehensive clean water initiative for Africa’s Great Lakes region. Both a live facility and a
TB kills 1.3 million people a year and sickens more than 10 million people annually. A new TB vaccine is needed to reach the global End TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants